DOJ, HHS Launch Six-Month FCA Self-Disclosure Pilot With Favored Terms
DOJ's Civil Division and HHS opened a six-month False Claims Act self-disclosure pilot for healthcare entities, promising favorable terms — though eligibility, protections and sunset mechanics still need reading from the program text.
On October 22, 2026, the DOJ Civil Division and HHS announced a six-month Healthcare False Claims Act Self-Disclosure Pilot Program, which the announcing firm (Ropes & Gray) describes as offering favorable terms. The available report is an excerpt, so the operative details are not confirmed here: the scope of qualifying self-disclosures, the treatment of potential liability, and any relator-claim or damages consequences are not set out in the material reviewed and should be verified against the published program materials before any entity relies on them.
Why sophisticated counsel should care: FCA exposure is existential for providers, and a treble-damages-plus-penalty theory per false claim can outweigh a payer's entire margin for the affected claim year. A time-boxed disclosure window converts a discretionary reporting decision into a calendared one, and the sequencing of internal investigation, disclosure and corrective action relative to an existing government inquiry is often outcome-determinative.
Concrete next steps to watch: pull the pilot's written terms, eligibility criteria and submission mechanics; map which open audits, overpayment reports or repayment obligations could qualify; and diarize the six-month sunset. In parallel, monitor for the first designations, any extension or conversion into permanent policy, and agency commentary on how the pilot interacts with existing corporate integrity agreements and qui tam actions.